Skip to main content

CBLN3 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-82995

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-82995-0.1ml

Key Product Details

Species Reactivity

Validated:

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Summary for CBLN3 Antibody

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of Human CBLN3. Peptide sequence: VCEPGRAAAGGPGGAALGEAPPGRVAFAAVRSHHHEPAGETGNGTSGAIY The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for CBLN3 Antibody

Western Blot: CBLN3 Antibody [NBP2-82995]

Western Blot: CBLN3 Antibody [NBP2-82995]

Western Blot: CBLN3 Antibody [NBP2-82995] - WB Suggested Anti-CBLN3 Antibody. Titration: 1.0 ug/ml. Positive Control: HepG2 Whole Cell

Applications for CBLN3 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: CBLN3

Alternate Names

cerebellin 3 precursor, cerebellin-3, PRO1486

Gene Symbol

CBLN3

Additional CBLN3 Products

Product Documents for CBLN3 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CBLN3 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...